HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 231 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,877,000 | -3.7% | 150,220 | 0.0% | 0.58% | -16.3% |
| Q2 2020 | $4,027,000 | +49.0% | 150,220 | 0.0% | 0.70% | +31.2% |
| Q1 2020 | $2,702,000 | +1.6% | 150,220 | +0.1% | 0.53% | +15.2% |
| Q4 2019 | $2,660,000 | -27.5% | 150,000 | -36.6% | 0.46% | -34.1% |
| Q3 2019 | $3,669,000 | -9.7% | 236,540 | 0.0% | 0.70% | -11.0% |
| Q2 2019 | $4,064,000 | +6.7% | 236,540 | 0.0% | 0.79% | -0.8% |
| Q1 2019 | $3,808,000 | +10.0% | 236,540 | 0.0% | 0.79% | -5.6% |
| Q4 2018 | $3,461,000 | – | 236,540 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |